These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15492774)

  • 1. A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor.
    Castelli MP; Pibiri F; Carboni G; Piras AP
    CNS Drug Rev; 2004; 10(3):243-60. PubMed ID: 15492774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain.
    Castelli MP; Mocci I; Pistis M; Peis M; Berta D; Gelain A; Gessa GL; Cignarella G
    Eur J Pharmacol; 2002 Jun; 446(1-3):1-5. PubMed ID: 12098579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of the gamma-hydroxybutyric acid receptor antagonist [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid in the rat brain.
    Mehta AK; Muschaweck NM; Maeda DY; Coop A; Ticku MK
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1148-53. PubMed ID: 11714906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
    Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
    Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative autoradiographic analysis of the new radioligand [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid ([(3)H]NCS-382) at gamma-hydroxybutyric acid (GHB) binding sites in rat brain.
    Gould GG; Mehta AK; Frazer A; Ticku MK
    Brain Res; 2003 Jul; 979(1-2):51-6. PubMed ID: 12850570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid.
    Carai MA; Colombo G; Brunetti G; Melis S; Serra S; Vacca G; Mastinu S; Pistuddi AM; Solinas C; Cignarella G; Minardi G; Gessa GL
    Eur J Pharmacol; 2001 Oct; 428(3):315-21. PubMed ID: 11689189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors.
    Nava F; Carta G; Bortolato M; Gessa GL
    Eur J Pharmacol; 2001 Nov; 430(2-3):261-3. PubMed ID: 11711039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro toxicological evaluation of NCS-382, a high-affinity antagonist of γ-hydroxybutyrate (GHB) binding.
    Vogel KR; Ainslie GR; Roullet JB; McConnell A; Gibson KM
    Toxicol In Vitro; 2017 Apr; 40():196-202. PubMed ID: 28119166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the discriminative stimulus effects of gamma-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382.
    Colombo G; Agabio R; Bourguignon J; Fadda F; Lobina C; Maitre M; Reali R; Schmitt M; Gessa GL
    Physiol Behav; 1995 Sep; 58(3):587-90. PubMed ID: 8587968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone.
    Carai MA; Lobina C; Maccioni P; Cabras C; Colombo G; Gessa GL
    J Pharmacol Sci; 2008 Feb; 106(2):199-207. PubMed ID: 18270475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand.
    Wu H; Zink N; Carter LP; Mehta AK; Hernandez RJ; Ticku MK; Lamb R; France CP; Coop A
    J Pharmacol Exp Ther; 2003 May; 305(2):675-9. PubMed ID: 12606613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel radioiodinated {gamma}-hydroxybutyric acid analogues for radiolabeling and Photolinking of high-affinity {gamma}-hydroxybutyric acid binding sites.
    Wellendorph P; Høg S; Sabbatini P; Pedersen MH; Martiny L; Knudsen GM; Frølund B; Clausen RP; Bräuner-Osborne H
    J Pharmacol Exp Ther; 2010 Nov; 335(2):458-64. PubMed ID: 20696866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and pharmacology of the GHB receptor.
    Ticku MK; Mehta AK
    Ann N Y Acad Sci; 2008 Oct; 1139():374-85. PubMed ID: 18991884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid.
    Castelli MP; Ferraro L; Mocci I; Carta F; Carai MA; Antonelli T; Tanganelli S; Cignarella G; Gessa GL
    J Neurochem; 2003 Nov; 87(3):722-32. PubMed ID: 14535954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists.
    Carter LP; Wu H; Chen W; Matthews MM; Mehta AK; Hernandez RJ; Thomson JA; Ticku MK; Coop A; Koek W; France CP
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1314-23. PubMed ID: 15769868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GHB receptor targets in the CNS: focus on high-affinity binding sites.
    Bay T; Eghorn LF; Klein AB; Wellendorph P
    Biochem Pharmacol; 2014 Jan; 87(2):220-8. PubMed ID: 24269284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects.
    Pistis M; Muntoni AL; Pillolla G; Perra S; Cignarella G; Melis M; Gessa GL
    Neuroscience; 2005; 131(2):465-74. PubMed ID: 15708487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence.
    Wu Y; Ali S; Ahmadian G; Liu CC; Wang YT; Gibson KM; Calver AR; Francis J; Pangalos MN; Carter Snead O
    Neuropharmacology; 2004 Dec; 47(8):1146-56. PubMed ID: 15567424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB).
    Absalom N; Eghorn LF; Villumsen IS; Karim N; Bay T; Olsen JV; Knudsen GM; Bräuner-Osborne H; Frølund B; Clausen RP; Chebib M; Wellendorph P
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13404-9. PubMed ID: 22753476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA(B)-receptor mediation of the inhibitory effect of gamma-hydroxybutyric acid on intestinal motility in mice.
    Carai MA; Agabio R; Lobina C; Reali R; Vacca G; Colombo G; Gessa GL
    Life Sci; 2002 May; 70(25):3059-67. PubMed ID: 12138019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.